In vitro Bioequivalence Studies in Tablet Formulation Containing 625 mg of Colesevelam Hydrochlorides
Gespeichert in:
| Veröffentlicht in: | Journal of bioequivalence & bioavailability 2017, Vol.9 (2) |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 2 |
| container_start_page | |
| container_title | Journal of bioequivalence & bioavailability |
| container_volume | 9 |
| creator | Tok, Gulcin Yildirim, Ediz Turkyilmaz, Ali |
| description | |
| doi_str_mv | 10.4172/jbb.1000323 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_4172_jbb_1000323</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_4172_jbb_1000323</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1153-e84ac82744455d404f4b4dd1b43f1118fddf58c84a266901ad0463d454e7bc73</originalsourceid><addsrcrecordid>eNpNkEFLAzEUhIMoWGpP_oHcZWuyedndHrVYWyh4sPclm7zUlGyiyXah_94We3AuMwzDHD5CHjmbA6_L50PXzTljTJTihkzYopYFayS__ZfvySznA7uoZlUDE4KbQEc3pEhfXcSfoxuVx6CRfg5H4zBTF-hOdR4HuoqpP3o1uBjoMoZBueDCnlalpP2eRnsuPWYc0auerk8mRf3lY3IG8wO5s8pnnF19Snart91yXWw_3jfLl22hOZeiwAaUbsoaAKQ0wMBCB8bwDoTlnDfWGCsbfV6VVbVgXBkGlTAgAetO12JKnv5udYo5J7Ttd3K9SqeWs_bCqD0zaq-MxC-e6Vnm</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>In vitro Bioequivalence Studies in Tablet Formulation Containing 625 mg of Colesevelam Hydrochlorides</title><source>Alma/SFX Local Collection</source><creator>Tok, Gulcin ; Yildirim, Ediz ; Turkyilmaz, Ali</creator><creatorcontrib>Tok, Gulcin ; Yildirim, Ediz ; Turkyilmaz, Ali</creatorcontrib><identifier>ISSN: 0975-0851</identifier><identifier>EISSN: 0975-0851</identifier><identifier>DOI: 10.4172/jbb.1000323</identifier><language>eng</language><ispartof>Journal of bioequivalence & bioavailability, 2017, Vol.9 (2)</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1153-e84ac82744455d404f4b4dd1b43f1118fddf58c84a266901ad0463d454e7bc73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids></links><search><creatorcontrib>Tok, Gulcin</creatorcontrib><creatorcontrib>Yildirim, Ediz</creatorcontrib><creatorcontrib>Turkyilmaz, Ali</creatorcontrib><title>In vitro Bioequivalence Studies in Tablet Formulation Containing 625 mg of Colesevelam Hydrochlorides</title><title>Journal of bioequivalence & bioavailability</title><issn>0975-0851</issn><issn>0975-0851</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpNkEFLAzEUhIMoWGpP_oHcZWuyedndHrVYWyh4sPclm7zUlGyiyXah_94We3AuMwzDHD5CHjmbA6_L50PXzTljTJTihkzYopYFayS__ZfvySznA7uoZlUDE4KbQEc3pEhfXcSfoxuVx6CRfg5H4zBTF-hOdR4HuoqpP3o1uBjoMoZBueDCnlalpP2eRnsuPWYc0auerk8mRf3lY3IG8wO5s8pnnF19Snart91yXWw_3jfLl22hOZeiwAaUbsoaAKQ0wMBCB8bwDoTlnDfWGCsbfV6VVbVgXBkGlTAgAetO12JKnv5udYo5J7Ttd3K9SqeWs_bCqD0zaq-MxC-e6Vnm</recordid><startdate>2017</startdate><enddate>2017</enddate><creator>Tok, Gulcin</creator><creator>Yildirim, Ediz</creator><creator>Turkyilmaz, Ali</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>2017</creationdate><title>In vitro Bioequivalence Studies in Tablet Formulation Containing 625 mg of Colesevelam Hydrochlorides</title><author>Tok, Gulcin ; Yildirim, Ediz ; Turkyilmaz, Ali</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1153-e84ac82744455d404f4b4dd1b43f1118fddf58c84a266901ad0463d454e7bc73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Tok, Gulcin</creatorcontrib><creatorcontrib>Yildirim, Ediz</creatorcontrib><creatorcontrib>Turkyilmaz, Ali</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of bioequivalence & bioavailability</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tok, Gulcin</au><au>Yildirim, Ediz</au><au>Turkyilmaz, Ali</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro Bioequivalence Studies in Tablet Formulation Containing 625 mg of Colesevelam Hydrochlorides</atitle><jtitle>Journal of bioequivalence & bioavailability</jtitle><date>2017</date><risdate>2017</risdate><volume>9</volume><issue>2</issue><issn>0975-0851</issn><eissn>0975-0851</eissn><doi>10.4172/jbb.1000323</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0975-0851 |
| ispartof | Journal of bioequivalence & bioavailability, 2017, Vol.9 (2) |
| issn | 0975-0851 0975-0851 |
| language | eng |
| recordid | cdi_crossref_primary_10_4172_jbb_1000323 |
| source | Alma/SFX Local Collection |
| title | In vitro Bioequivalence Studies in Tablet Formulation Containing 625 mg of Colesevelam Hydrochlorides |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T10%3A26%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20Bioequivalence%20Studies%20in%20Tablet%20Formulation%20Containing%20625%20mg%20of%20Colesevelam%20Hydrochlorides&rft.jtitle=Journal%20of%20bioequivalence%20&%20bioavailability&rft.au=Tok,%20Gulcin&rft.date=2017&rft.volume=9&rft.issue=2&rft.issn=0975-0851&rft.eissn=0975-0851&rft_id=info:doi/10.4172/jbb.1000323&rft_dat=%3Ccrossref%3E10_4172_jbb_1000323%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |